High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles

[Image: see text] Non-Hodgkin lymphoma is one of the most common types of cancer. Relapsed and refractory diseases are still common and remain significant challenges as the majority of these patients eventually succumb to the disease. Herein, we report a translatable concurrent chemo-immuno-radiothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Au, Kin Man, Balhorn, Rod, Balhorn, Monique C., Park, Steven I., Wang, Andrew Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346391/
https://www.ncbi.nlm.nih.gov/pubmed/30693332
http://dx.doi.org/10.1021/acscentsci.8b00746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346391/
https://www.ncbi.nlm.nih.gov/pubmed/30693332
http://dx.doi.org/10.1021/acscentsci.8b00746

Ejemplares similares